2026年全球性行為感染傳染病分子診斷市場報告

近年來，性行為感染（STD）分子診斷市場發展迅速，預計將從2025年的36.7億美元成長到2026年的40.7億美元，複合年成長率達10.7%。成長要素包括：對傳統血清學檢測的依賴、自動化PCR系統普及率低、新興市場對分子診斷的認知度低、性行為感染的日益流行以及人工操作流程和勞動密集型檢測方法。

預計未來幾年，性行為感染（STD）分子診斷市場將快速成長，到2030年市場規模將達到60.5億美元，複合年成長率（CAGR）為10.4%。預測期間的成長要素包括：自動化PCR和核酸萃取技術的進步、照護現場分子診斷的普及、發展中地區醫療基礎設施的完善、實驗室資訊管理系統（LIMS）的日益普及，以及對快速多重診斷檢測的研發投入不斷增加。預測期內的主要趨勢包括：核酸檢測方法的日益普及、照護現場分子診斷解決方案的擴展、對快速準確檢測性行為感染的需求不斷成長、分子診斷與實驗室資訊系統的整合，以及自動化PCR和高通量診斷平台的發展。

性行為感染感染（STI）的日益普及預計將在未來幾年推動性行為感染分子診斷市場的成長。性行為感染是由細菌、病毒和寄生蟲引起的感染疾病，透過性接觸傳播，主要影響生殖系統和泌尿器官系統。這種日益流行的趨勢主要是由於防護措施使用不當，導致性活躍人群中傳播疾病。性性行為感染的分子診斷在控制這些感染疾病發揮著至關重要的作用，它能夠早期、準確地檢測病原體，即使在無症狀感染者中也能進行檢測，從而支持及時治療，遏制疾病傳播，並改善患者的整體預後。例如，根據英國政府機構英國健康安全局（UKHSA）於2024年6月發布的數據，2023年英格蘭將新增401,800例性性行為感染，比2022年的383,789例成長4.7%。因此，性行為感染的上升趨勢正在推動性行為感染分子診斷市場的成長。

為了提高診斷的速度、準確性和可及性，該市場的主要企業正致力於技術創新，例如快速照護現場聚合酵素鏈鎖反應(PCR) 設備。這些攜帶式設備將樣本製備、擴增和檢測整合於一體，可在傳統實驗室之外實現高靈敏度的病原體檢測。例如，2025 年 3 月，總部位於美國的診斷技術公司 Visby Medical 推出了 Visby Medical 女性性健康檢測。這款一次性攜帶式PCR 設備可在 30 分鐘內檢測陰道樣本中的披衣菌感染、淋病和滴蟲病，無需外部設備或低溫運輸物流。該產品已獲準憑處方箋在家使用，是首個獲得 FDA 批准可在臨床環境之外用於多種性行為感染傳染病的分子診斷檢測產品，體現了去中心化和可及性檢測的發展趨勢。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球性行為感染傳染病分子診斷市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 主要原料、資源和供應商清單
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章 全球市場趨勢與策略

• 關鍵技術和未來趨勢
  • 生物技術、基因組學和精準醫學
  • 數位化、雲端運算、巨量資料、網路安全
  • 工業4.0和智慧製造
  • 人工智慧（AI）和自主人工智慧
  • 物聯網、智慧基礎設施和互聯生態系統
• 主要趨勢
  • 核酸檢測技術的日益普及
  • 擴展照護現場分子診斷解決方案
  • 對快速且準確的性行為感染傳染病（STD）檢測的需求日益成長
  • 整合分子診斷與實驗室資訊系統
  • 自動化PCR和高通量診斷平台的發展

第5章 終端用戶產業市場分析

• 臨床檢查室
• 醫院和診所
• 診斷服務提供者
• 研究和學術機構
• 公共衛生機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球性行為感染傳染病分子診斷市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 全球性行為感染傳染病分子診斷市場規模、比較及成長率分析
• 全球性行為感染傳染病分子診斷市場表現：規模與成長，2020-2025年
• 全球性行為感染傳染病分子診斷市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

• 依產品
• 設備、服務、耗材、軟體
• 透過技術
• 檢查室，就地檢驗
• 透過使用
• 披衣菌感染衣原體 (CT) 或淋病奈瑟菌 (NG) 檢測、梅毒檢測、淋病檢測、單純皰疹病毒 (HSV) 檢測、人類乳突病毒 (HPV) 檢測、人類免疫力缺乏病毒 (HIV) 檢測、滴蟲、脲原體和黴漿菌檢測，以及其他用途
• 按類型細分：設備和服務
• 分子診斷分析儀、自動化聚合酵素鏈鎖反應系統、核酸萃取設備、診斷服務供應商、維護和校準服務、安裝和訓練服務
• 按類型細分：消耗品
• 去氧核糖核酸萃取試劑盒、核糖核酸萃取試劑盒、聚合酵素鏈鎖反應試劑、核酸探針、對照品和參考標準品、檢測酵素和緩衝溶液
• 按類型細分：軟體
• 數據解讀與報告軟體、聚合酵素鏈鎖反應工作流程管理軟體、實驗室資訊管理系統、診斷決策支援軟體、品管監控軟體

第10章 區域與國家分析

• 全球性行為感染傳染病分子診斷市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
• 全球性行為感染傳染病分子診斷市場：國家、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 性行為感染傳染病分子診斷市場：競爭格局及市場佔有率（2024年）
• 性行為感染傳染病分子診斷市場：公司估值矩陣
• 性行為感染傳染病分子診斷市場：公司概況
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Illumina Inc.

第37章：其他領先和創新企業

• Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, QIAGEN NV, Cepheid, Sansure Biotech Inc., OraSure Technologies Inc., Meridian Bioscience, Seegene Inc., Visby Medical Inc., Zeesan Biotech, Binx Health Inc., GCC Biotech, GeneProof, Solone Life Sciences India（P）Ltd.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

• 2030年性行為感染傳染病分子診斷市場：提供新機會的國家
• 2030年性行為感染傳染病分子診斷市場：充滿新機會的細分領域
• 2030年性行為感染傳染病分子診斷市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第41章附錄

Molecular diagnostics for sexually transmitted diseases (STDs) involve methods that detect the genetic material, DNA or RNA of infectious agents to confirm the presence of pathogens. These techniques are highly accurate and sensitive, allowing detection even in asymptomatic cases. By analyzing the molecular structure of pathogens, these diagnostics ensure reliable identification, supporting faster and more precise diagnosis.

The primary product categories for molecular diagnostics of STDs include instruments and services, consumables, and software. Instruments comprise the diagnostic devices and platforms used for pathogen detection, while services cover laboratory testing, sample processing, and interpretation of diagnostic results provided by healthcare or diagnostic companies. These diagnostics employ various technologies, including laboratory-based testing and point-of-care testing, and are used in a range of applications such as testing for chlamydia trachomatis (CT), neisseria gonorrhoeae (NG), syphilis, gonorrhea, herpes simplex virus (HSV), human papillomavirus (HPV), human immunodeficiency virus (HIV), trichomonas, ureaplasma, mycoplasma, and others.

Tariffs have influenced the molecular diagnostics for sexually transmitted diseases market by increasing the cost of imported instruments, PCR reagents, and nucleic acid extraction kits. Laboratory testing and point-of-care testing segments are particularly affected, with regions such as North America and Asia-Pacific facing higher import duties. This has led to increased operational costs for diagnostic laboratories and service providers. On the positive side, tariffs have encouraged local manufacturing, adoption of alternative suppliers, and development of cost-effective diagnostic solutions.

The molecular diagnostics for sexually transmitted diseases market research report is one of a series of new reports from The Business Research Company that provides molecular diagnostics for sexually transmitted diseases market statistics, including molecular diagnostics for sexually transmitted diseases industry global market size, regional shares, competitors with a molecular diagnostics for sexually transmitted diseases market share, detailed molecular diagnostics for sexually transmitted diseases market segments, market trends and opportunities, and any further data you may need to thrive in the molecular diagnostics for sexually transmitted diseases industry. This molecular diagnostics for sexually transmitted diseases market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The molecular diagnostics for sexually transmitted diseases market size has grown rapidly in recent years. It will grow from $3.67 billion in 2025 to $4.07 billion in 2026 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to reliance on conventional serological tests, limited availability of automated pcr systems, low awareness of molecular diagnostics in emerging markets, growing prevalence of sexually transmitted infections, manual workflow and labor-intensive testing.

The molecular diagnostics for sexually transmitted diseases market size is expected to see rapid growth in the next few years. It will grow to $6.05 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to technological advancements in automated pcr and nucleic acid extraction, expansion of point-of-care molecular diagnostics, increasing healthcare infrastructure in developing regions, rising adoption of laboratory information management systems (lims), growing investment in r&d for rapid and multiplexed diagnostic assays. Major trends in the forecast period include increasing adoption of nucleic acid-based testing methods, expansion of point-of-care molecular diagnostic solutions, rising demand for rapid and accurate std detection, integration of molecular diagnostics with laboratory information systems, growth in automated pcr and high-throughput diagnostic platforms.

The increasing prevalence of sexually transmitted infections (STIs) is expected to drive the growth of the molecular diagnostics for sexually transmitted diseases market in the coming years. STIs are infections caused by bacteria, viruses, or parasites that are transmitted through sexual contact, affecting the reproductive and urinary systems. Their rising prevalence is largely attributed to inconsistent use of protection methods, which facilitates easier transmission among sexually active individuals. Molecular diagnostics for STIs play a vital role in managing these infections by enabling early and accurate detection of pathogens, even in asymptomatic cases, thereby supporting timely treatment, reducing disease transmission, and improving overall patient outcomes. For example, in June 2024, the UK Health Security Agency (UKHSA), a UK-based government agency, reported that in 2023 there were 401,800 new STI diagnoses in England, representing a 4.7% increase compared to 383,789 cases in 2022. Consequently, the rising prevalence of sexually transmitted infections is fueling the growth of the molecular diagnostics for sexually transmitted diseases market.

Key companies in this market are focusing on innovations such as rapid point-of-care polymerase chain reaction (PCR) devices to enhance diagnostic speed, accuracy, and accessibility. These portable devices combine sample preparation, amplification, and detection in a single unit, enabling sensitive pathogen detection outside traditional labs. For instance, in March 2025, Visby Medical, a US-based diagnostic technology company, launched the Visby Medical Women's Sexual Health Test. This single-use, handheld PCR device identifies chlamydia, gonorrhea, and trichomoniasis from vaginal samples in 30 minutes without external instrumentation or cold-chain logistics. Authorized for prescription home use, it represents the first FDA-cleared molecular diagnostic test for multiple STIs usable outside clinical settings, reflecting the trend toward decentralized, accessible testing.

In December 2024, OraSure Technologies, a US-based provider of point-of-care and home diagnostic solutions, acquired Sherlock Biosciences. This acquisition expanded OraSure's molecular diagnostics portfolio in sexual health by integrating Sherlock's over-the-counter chlamydia and gonorrhea self-test, which delivers lab-quality results in under 30 minutes using CRISPR- and isothermal amplification-based platforms. Sherlock Biosciences specializes in molecular diagnostics for sexually transmitted infections.

Major companies operating in the molecular diagnostics for sexually transmitted diseases market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Illumina Inc., Hologic Inc., bioMerieux S.A., QuidelOrtho Corporation, QIAGEN N.V., Cepheid, Sansure Biotech Inc., OraSure Technologies Inc., Meridian Bioscience, Seegene Inc., Visby Medical Inc., Zeesan Biotech, Binx Health Inc., GCC Biotech, GeneProof, Solone Life Sciences India (P) Ltd.

North America was the largest region in the molecular diagnostics for sexually transmitted diseases market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics for sexually transmitted diseases market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the molecular diagnostics for sexually transmitted diseases market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The molecular diagnostics for sexually transmitted diseases market consists of revenues earned by entities by providing services such as test development, sample collection, nucleic acid amplification, and point of care diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The molecular diagnostics for sexually transmitted diseases market also includes sales of polymerase chain reaction kits, isothermal nucleic acid amplification kits, clustered regularly interspaced short palindromic repeats-based tests, and instrument-free molecular diagnostic systems. values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Molecular Diagnostics For Sexually Transmitted Diseases Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses molecular diagnostics for sexually transmitted diseases market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for molecular diagnostics for sexually transmitted diseases ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The molecular diagnostics for sexually transmitted diseases market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Instruments And Services; Consumables; Software
• 2) By Technology: Laboratory Testing; Point-Of-Care Testing
• 3) By Application: Chlamydia Trachomatis (CT) Or Neisseria Gonorrhoeae (NG) Testing; Syphilis Testing; Gonorrhea Testing; Herpes Simplex Virus (HSV) Testing; Human Papillomavirus (HPV) Testing; Human Immunodeficiency Virus (HIV) Testing; Trichomonas; Ureaplasma And Mycoplasma; Other Applications
• Subsegments:
• 1) By Instruments And Services: Molecular Diagnostic Analyzers; Automated Polymerase Chain Reaction Systems; Nucleic Acid Extraction Instruments; Diagnostic Service Providers; Maintenance And Calibration Services; Installation And Training Services
• 2) By Consumables: Deoxyribonucleic Acid Extraction Kits; Ribonucleic Acid Extraction Kits; Polymerase Chain Reaction Reagents; Nucleic Acid Probes; Control And Reference Standards; Detection Enzymes And Buffers
• 3) By Software: Data Interpretation And Reporting Software; Polymerase Chain Reaction Workflow Management Software; Laboratory Information Management Systems; Diagnostic Decision Support Software; Quality Control Monitoring Software
• Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers AG; Illumina Inc.; Hologic Inc.; bioMerieux S.A.; QuidelOrtho Corporation; QIAGEN N.V.; Cepheid; Sansure Biotech Inc.; OraSure Technologies Inc.; Meridian Bioscience; Seegene Inc.; Visby Medical Inc.; Zeesan Biotech; Binx Health Inc.; GCC Biotech; GeneProof; Solone Life Sciences India (P) Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Molecular Diagnostics For Sexually Transmitted Diseases Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Molecular Diagnostics For Sexually Transmitted Diseases Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Molecular Diagnostics For Sexually Transmitted Diseases Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Molecular Diagnostics For Sexually Transmitted Diseases Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Nucleic Acid-Based Testing Methods
  • 4.2.2 Expansion Of Point-Of-Care Molecular Diagnostic Solutions
  • 4.2.3 Rising Demand For Rapid And Accurate Std Detection
  • 4.2.4 Integration Of Molecular Diagnostics With Laboratory Information Systems
  • 4.2.5 Growth In Automated Pcr And High-Throughput Diagnostic Platforms

5. Molecular Diagnostics For Sexually Transmitted Diseases Market Analysis Of End Use Industries

• 5.1 Clinical Laboratories
• 5.2 Hospitals And Clinics
• 5.3 Diagnostic Service Providers
• 5.4 Research And Academic Institutions
• 5.5 Public Health Organizations

6. Molecular Diagnostics For Sexually Transmitted Diseases Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Molecular Diagnostics For Sexually Transmitted Diseases Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Molecular Diagnostics For Sexually Transmitted Diseases PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Molecular Diagnostics For Sexually Transmitted Diseases Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Molecular Diagnostics For Sexually Transmitted Diseases Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Molecular Diagnostics For Sexually Transmitted Diseases Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Molecular Diagnostics For Sexually Transmitted Diseases Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Molecular Diagnostics For Sexually Transmitted Diseases Market Segmentation

• 9.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Instruments And Services, Consumables, Software
• 9.2. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Laboratory Testing, Point-Of-Care Testing
• 9.3. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Chlamydia Trachomatis (CT) Or Neisseria Gonorrhoeae (NG) Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus (HSV) Testing, Human Papillomavirus (HPV) Testing, Human Immunodeficiency Virus (HIV) Testing, Trichomonas, Ureaplasma And Mycoplasma, Other Applications
• 9.4. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Sub-Segmentation Of Instruments And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Molecular Diagnostic Analyzers, Automated Polymerase Chain Reaction Systems, Nucleic Acid Extraction Instruments, Diagnostic Service Providers, Maintenance And Calibration Services, Installation And Training Services
• 9.5. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Nucleic Acid Probes, Control And Reference Standards, Detection Enzymes And Buffers
• 9.6. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Data Interpretation And Reporting Software, Polymerase Chain Reaction Workflow Management Software, Laboratory Information Management Systems, Diagnostic Decision Support Software, Quality Control Monitoring Software

10. Molecular Diagnostics For Sexually Transmitted Diseases Market Regional And Country Analysis

• 10.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Molecular Diagnostics For Sexually Transmitted Diseases Market

• 11.1. Asia-Pacific Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Molecular Diagnostics For Sexually Transmitted Diseases Market

• 12.1. China Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Molecular Diagnostics For Sexually Transmitted Diseases Market

• 13.1. India Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Molecular Diagnostics For Sexually Transmitted Diseases Market

• 14.1. Japan Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Molecular Diagnostics For Sexually Transmitted Diseases Market

• 15.1. Australia Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Molecular Diagnostics For Sexually Transmitted Diseases Market

• 16.1. Indonesia Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Molecular Diagnostics For Sexually Transmitted Diseases Market

• 17.1. South Korea Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Molecular Diagnostics For Sexually Transmitted Diseases Market

• 18.1. Taiwan Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Molecular Diagnostics For Sexually Transmitted Diseases Market

• 19.1. South East Asia Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Molecular Diagnostics For Sexually Transmitted Diseases Market

• 20.1. Western Europe Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Molecular Diagnostics For Sexually Transmitted Diseases Market

• 21.1. UK Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Molecular Diagnostics For Sexually Transmitted Diseases Market

• 22.1. Germany Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Molecular Diagnostics For Sexually Transmitted Diseases Market

• 23.1. France Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Molecular Diagnostics For Sexually Transmitted Diseases Market

• 24.1. Italy Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Molecular Diagnostics For Sexually Transmitted Diseases Market

• 25.1. Spain Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Molecular Diagnostics For Sexually Transmitted Diseases Market

• 26.1. Eastern Europe Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Molecular Diagnostics For Sexually Transmitted Diseases Market

• 27.1. Russia Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Molecular Diagnostics For Sexually Transmitted Diseases Market

• 28.1. North America Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Molecular Diagnostics For Sexually Transmitted Diseases Market

• 29.1. USA Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Molecular Diagnostics For Sexually Transmitted Diseases Market

• 30.1. Canada Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Molecular Diagnostics For Sexually Transmitted Diseases Market

• 31.1. South America Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Molecular Diagnostics For Sexually Transmitted Diseases Market

• 32.1. Brazil Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Molecular Diagnostics For Sexually Transmitted Diseases Market

• 33.1. Middle East Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Molecular Diagnostics For Sexually Transmitted Diseases Market

• 34.1. Africa Molecular Diagnostics For Sexually Transmitted Diseases Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Molecular Diagnostics For Sexually Transmitted Diseases Market, Segmentation By Product, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Molecular Diagnostics For Sexually Transmitted Diseases Market Regulatory and Investment Landscape

36. Molecular Diagnostics For Sexually Transmitted Diseases Market Competitive Landscape And Company Profiles

• 36.1. Molecular Diagnostics For Sexually Transmitted Diseases Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Molecular Diagnostics For Sexually Transmitted Diseases Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Molecular Diagnostics For Sexually Transmitted Diseases Market Company Profiles
  • 36.3.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Molecular Diagnostics For Sexually Transmitted Diseases Market Other Major And Innovative Companies

• Hologic Inc., bioMerieux S.A., QuidelOrtho Corporation, QIAGEN N.V., Cepheid, Sansure Biotech Inc., OraSure Technologies Inc., Meridian Bioscience, Seegene Inc., Visby Medical Inc., Zeesan Biotech, Binx Health Inc., GCC Biotech, GeneProof, Solone Life Sciences India (P) Ltd.

38. Global Molecular Diagnostics For Sexually Transmitted Diseases Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Molecular Diagnostics For Sexually Transmitted Diseases Market

40. Molecular Diagnostics For Sexually Transmitted Diseases Market High Potential Countries, Segments and Strategies

• 40.1 Molecular Diagnostics For Sexually Transmitted Diseases Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Molecular Diagnostics For Sexually Transmitted Diseases Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Molecular Diagnostics For Sexually Transmitted Diseases Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer